Literature DB >> 24285243

Drug resistance: making a point.

Nicola McCarthy.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24285243     DOI： 10.1038/nrc3649

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  3 in total

1.  D538G mutation in estrogen receptor-α: A novel mechanism for acquired endocrine resistance in breast cancer.

Authors:  Keren Merenbakh-Lamin; Noa Ben-Baruch; Adva Yeheskel; Addie Dvir; Lior Soussan-Gutman; Rinath Jeselsohn; Roman Yelensky; Myles Brown; Vincent A Miller; David Sarid; Shulamith Rizel; Baruch Klein; Tami Rubinek; Ido Wolf
Journal:  Cancer Res       Date:  2013-11-11       Impact factor: 12.701

2.  Activating ESR1 mutations in hormone-resistant metastatic breast cancer.

Authors:  Dan R Robinson; Yi-Mi Wu; Pankaj Vats; Fengyun Su; Robert J Lonigro; Xuhong Cao; Shanker Kalyana-Sundaram; Rui Wang; Yu Ning; Lynda Hodges; Amy Gursky; Javed Siddiqui; Scott A Tomlins; Sameek Roychowdhury; Kenneth J Pienta; Scott Y Kim; J Scott Roberts; James M Rae; Catherine H Van Poznak; Daniel F Hayes; Rashmi Chugh; Lakshmi P Kunju; Moshe Talpaz; Anne F Schott; Arul M Chinnaiyan
Journal:  Nat Genet       Date:  2013-11-03       Impact factor: 38.330

3.  ESR1 ligand-binding domain mutations in hormone-resistant breast cancer.

Authors:  Weiyi Toy; Yang Shen; Helen Won; Bradley Green; Rita A Sakr; Marie Will; Zhiqiang Li; Kinisha Gala; Sean Fanning; Tari A King; Clifford Hudis; David Chen; Tetiana Taran; Gabriel Hortobagyi; Geoffrey Greene; Michael Berger; José Baselga; Sarat Chandarlapaty
Journal:  Nat Genet       Date:  2013-11-03       Impact factor: 38.330
  3 in total
  2 in total

1.  Cancer network activity associated with therapeutic response and synergism.

Authors:  Jordi Serra-Musach; Francesca Mateo; Eva Capdevila-Busquets; Gorka Ruiz de Garibay; Xiaohu Zhang; Raj Guha; Craig J Thomas; Judit Grueso; Alberto Villanueva; Samira Jaeger; Holger Heyn; Miguel Vizoso; Hector Pérez; Alex Cordero; Eva Gonzalez-Suarez; Manel Esteller; Gema Moreno-Bueno; Andreas Tjärnberg; Conxi Lázaro; Violeta Serra; Joaquín Arribas; Mikael Benson; Mika Gustafsson; Marc Ferrer; Patrick Aloy; Miquel Àngel Pujana
Journal:  Genome Med       Date:  2016-08-24       Impact factor: 11.117

2.  Reverse of non-small cell lung cancer drug resistance induced by cancer-associated fibroblasts via a paracrine pathway.

Authors:  Quanhui Zhang; Junping Yang; Jie Bai; Jianzhuang Ren
Journal:  Cancer Sci       Date:  2018-03-25       Impact factor: 6.716
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.